STCOSD
BIO icon

Sageworth Trust Company of South Dakota’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10
Closed -$5K – 286
2022
Q2 		$5K Hold
10
– – 0.01% 226
2022
Q1 		$6K Sell
10
-47
-82% -$28.3K 0.01% 261
2021
Q4 		$43K Buy
+57
New +$42.7K 0.07% 117

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sageworth Trust Company of South Dakota's BIO Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 10 shares — an estimated $5K sold.

Sageworth Trust Company of South Dakota first reported a position in BIO in Q4 2021 and held it in 3 quarters. The position peaked at $43K in Q4 2021. 486 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 10 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $5K.
  • Sageworth Trust Company of South Dakota first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Bio-Rad Laboratories Class A position peaked at $43K in Q4 2021.
  • 486 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.